Rein in Sarcoma’s Board approved a $50,000 research grant to the University of Minnesota. The University solicited requests for funding proposals from their researchers, blindly ranking them according to national standards, and then recommended the proposal submitted by Erin Dickerson, PhD. Project Title: Targeting the Cell Cycle and Autophagy Reciprocal Communication Pathways in Sarcomas Principal…
Friday, March 31 at the University of Minnesota On Friday, March 31 Rein in Sarcoma hosted with Dr. Brenda Weigel of the Masonic Cancer Center our sixth annual Sarcoma Research Symposium featuring speakers who have received grants funded by the work of our community. After a light breakfast and warm welcome from Dr. Weigel, twenty-seven…
We invite you to join us for the Minnesota Sarcoma Research Conference 2023: Progress and Promise, a hybrid event sponsored by Rein in Sarcoma (RIS) and the Masonic Cancer Center, University of Minnesota The Progress and Promise Sarcoma Research Conference is a forum for researchers to share their findings to RIS stakeholders and students and…
Friday, March 31 at the University of Minnesota This year, we welcome out of state scientist, Berkley Gryder, Ph.D., who serves as principal investigator on the Rein in Sarcoma Kasey Altman Research Fund Grant for alvar rhabdomyosarcoma (ARMS) research at Case Western Reserve University. Initiated in 2021 and titled the Identification of new strategies to…
University of Minnesota Nea Fride is a MSY3 at the University of Minnesota Medical School. She has a BA and BSM from Newcomb College at Tulane University in New Orleans, Louisiana and a MS as a Pathologists’ Assistant from the University of Maryland at Baltimore. Before medical school, she worked in the field of pathology…
Expanding our understanding of DICERJ-related sarcomasPrincipal Investigator: Kris Ann Schultz, MD Project summary: DICERJ-related sarcomas include pleuropulmonary blastoma (PPB), renal sarcoma, ovarian, cervical and uterine sarcoma, renal sarcoma and PPB-like pelitoneal sarcoma which may arise from peritoneal structures. In addition, Sertoli-Leydig cell tumor (SLCT), a rare ovarian tumor seen primarily in girls and young women,…
Kris Ann P. Schultz, M.D. shares insights into sarcoma research and treatment Researchers are making progress, with Rein in Sarcoma’s help, in the quest to understand, treat, and prevent sarcoma. Kris Ann P. Schultz, M.D., a pediatric oncologist with Children’s Minnesota, has been involved in both clinical care and research for many years. A recipient…
On March 25, 2022, the Rein in Sarcoma community hosted the annual Research Symposium where 2019 and 2020 grant-winners showcased their research. The gathering was held in a hybrid format where viewers could watch the speeches online if they weren’t unable to attend in person. A total of 29 viewers from across the country tuned…
Rein in Sarcoma’s Board approved a $50,000 research grant to the University of Minnesota at its February, 2022 meeting. The University solicited requests for funding proposals from their researchers, blindly ranking them according to national standards, and then recommended the proposal submitted by Dr. Beau Webber, PhD. Project Title: Characterization of Ewing Sarcoma patient-derived induced…
Rein in Sarcoma is excited to announce a $54,000 sarcoma research grant has been awarded to Case Western Reserve University. Case Western Reserve University: Identification of new strategies to therapeutically intervene for rhabdomyosarcomas Principal Investigator: Berkley E. Gryder, Ph.D. Project summary: This project will expand the identification of new strategies to therapeutically intervene for rhabdomyosarcomas…
